Skip to main content
Top
Published in: Strahlentherapie und Onkologie 4/2019

01-04-2019 | Original Article

Comparison of treatment plans for a high-field MRI-linac and a conventional linac for esophageal cancer

Authors: Marcel Nachbar, David Mönnich, Paul Kalwa, Daniel Zips, Daniela Thorwarth, Dr. Cihan Gani

Published in: Strahlentherapie und Onkologie | Issue 4/2019

Login to get access

Abstract

Purpose

To compare radiotherapy treatments plans in esophageal cancer calculated for a high-field magnetic resonance imaging (MRI)-linac with plans for a conventional linac.

Materials and methods

Ten patients with esophageal squamous cell carcinomas were re-planned retrospectively using the research version of Monaco (V 5.19.03, Elekta AB, Stockholm, Sweden). Intensity modulated radiotherapy (IMRT) plans with a nine-field step-and-shoot technique and two-arc volumetric modulated arc therapy (VMAT) plans were created for the Elekta MRI-linac and a conventional linac, respectively. The prescribed dose was 60 Gy to the primary tumor (PTV60) and 50 Gy to elective volumes (PTV50). Plans were optimized for optimal coverage of the 60 Gy volume and compared using dose–volume histogram parameters.

Results

All calculated treatment plans met predefined criteria for target volume coverage and organs at risk dose both for MRI-linac and conventional linac. Plans for the MRI-linac had a lower number of segments and monitor units. No significant differences between both plans were seen in terms of V20Gy of the lungs and V40Gy of the heart with slightly higher mean doses to the heart (14.0 Gy vs. 12.5 Gy) and lungs (12.8 Gy vs. 12.2 Gy).

Conclusion

Applying conventional target volume and margin concepts as well as dose-fractionation prescription reveals clinically acceptable dose distributions using hybrid MRI-linac in its current configuration compared to standard IMRT/VMAT. This represents an important prerequisite for future studies to investigate the clinical benefit of MRI-guided radiotherapy exploiting the conceptional advantages such as reduced margins, plan adaptation and biological individualization and hypofractionation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Munch S, Oechsner M, Combs SE, Habermehl D (2017) DVH- and NTCP-based dosimetric comparison of different longitudinal margins for VMAT-IMRT of esophageal cancer. Radiat Oncol 12:128CrossRefPubMedPubMedCentral Munch S, Oechsner M, Combs SE, Habermehl D (2017) DVH- and NTCP-based dosimetric comparison of different longitudinal margins for VMAT-IMRT of esophageal cancer. Radiat Oncol 12:128CrossRefPubMedPubMedCentral
2.
go back to reference van Rossum PS, van Lier AL, van Vulpen M et al (2015) Diffusion-weighted magnetic resonance imaging for the prediction of pathologic response to neoadjuvant chemoradiotherapy in esophageal cancer. Radiother Oncol 115:163–170CrossRefPubMed van Rossum PS, van Lier AL, van Vulpen M et al (2015) Diffusion-weighted magnetic resonance imaging for the prediction of pathologic response to neoadjuvant chemoradiotherapy in esophageal cancer. Radiother Oncol 115:163–170CrossRefPubMed
3.
go back to reference Raaijmakers AJ, Hardemark B, Raaymakers BW, Raaijmakers CP, Lagendijk JJ (2007) Dose optimization for the MRI-accelerator: IMRT in the presence of a magnetic field. Phys Med Biol 52:7045–7054CrossRefPubMed Raaijmakers AJ, Hardemark B, Raaymakers BW, Raaijmakers CP, Lagendijk JJ (2007) Dose optimization for the MRI-accelerator: IMRT in the presence of a magnetic field. Phys Med Biol 52:7045–7054CrossRefPubMed
4.
go back to reference Lagendijk JJ, Raaymakers BW, Raaijmakers AJ et al (2008) MRI/linac integration. Radiother Oncol 86:25–29CrossRefPubMed Lagendijk JJ, Raaymakers BW, Raaijmakers AJ et al (2008) MRI/linac integration. Radiother Oncol 86:25–29CrossRefPubMed
5.
go back to reference Yang YM, Geurts M, Smilowitz JB, Sterpin E, Bednarz BP (2015) Monte Carlo simulations of patient dose perturbations in rotational-type radiotherapy due to a transverse magnetic field: a tomotherapy investigation. Med Phys 42:715–725CrossRefPubMedPubMedCentral Yang YM, Geurts M, Smilowitz JB, Sterpin E, Bednarz BP (2015) Monte Carlo simulations of patient dose perturbations in rotational-type radiotherapy due to a transverse magnetic field: a tomotherapy investigation. Med Phys 42:715–725CrossRefPubMedPubMedCentral
6.
go back to reference Wu AJ, Bosch WR, Chang DT et al (2015) Expert consensus contouring guidelines for intensity modulated radiation therapy in esophageal and gastroesophageal junction cancer. Int J Radiat Oncol Biol Phys 92:911–920CrossRefPubMedPubMedCentral Wu AJ, Bosch WR, Chang DT et al (2015) Expert consensus contouring guidelines for intensity modulated radiation therapy in esophageal and gastroesophageal junction cancer. Int J Radiat Oncol Biol Phys 92:911–920CrossRefPubMedPubMedCentral
7.
go back to reference Chen X, Prior P, Chen G‑P, Schultz CJ, Li XA (2016) Technical note: dose effects of 1.5 T transverse magnetic field on tissue interfaces in MRI-guided radiotherapy. Med Phys 43:4797–4802CrossRefPubMed Chen X, Prior P, Chen G‑P, Schultz CJ, Li XA (2016) Technical note: dose effects of 1.5 T transverse magnetic field on tissue interfaces in MRI-guided radiotherapy. Med Phys 43:4797–4802CrossRefPubMed
8.
go back to reference Schrenk O, Spindeldreier CK, Burigo LN, Hoerner-Rieber J, Pfaffenberger A (2017) Effects of magnetic field orientation and strength on the treatment planning of nonsmall cell lung cancer. Med Phys 44:6621–6631CrossRefPubMed Schrenk O, Spindeldreier CK, Burigo LN, Hoerner-Rieber J, Pfaffenberger A (2017) Effects of magnetic field orientation and strength on the treatment planning of nonsmall cell lung cancer. Med Phys 44:6621–6631CrossRefPubMed
9.
go back to reference Beukema JC, van Luijk P, Widder J, Langendijk JA, Muijs CT (2015) Is cardiac toxicity a relevant issue in the radiation treatment of esophageal cancer? Radiother Oncol 114:85–90CrossRefPubMed Beukema JC, van Luijk P, Widder J, Langendijk JA, Muijs CT (2015) Is cardiac toxicity a relevant issue in the radiation treatment of esophageal cancer? Radiother Oncol 114:85–90CrossRefPubMed
10.
go back to reference van Nimwegen FA, Schaapveld M, Cutter DJ et al (2016) Radiation dose-response relationship for risk of coronary heart disease in survivors of Hodgkin lymphoma. J Clin Oncol 34:235–243CrossRefPubMed van Nimwegen FA, Schaapveld M, Cutter DJ et al (2016) Radiation dose-response relationship for risk of coronary heart disease in survivors of Hodgkin lymphoma. J Clin Oncol 34:235–243CrossRefPubMed
11.
go back to reference Wang K, Eblan MJ, Deal AM et al (2017) Cardiac toxicity after radiotherapy for stage III non-small-cell lung cancer: pooled analysis of dose-escalation trials delivering 70 to 90 Gy. J Clin Oncol 35:1387–1394CrossRefPubMedPubMedCentral Wang K, Eblan MJ, Deal AM et al (2017) Cardiac toxicity after radiotherapy for stage III non-small-cell lung cancer: pooled analysis of dose-escalation trials delivering 70 to 90 Gy. J Clin Oncol 35:1387–1394CrossRefPubMedPubMedCentral
12.
go back to reference van Heijst TC, den Hartogh MD, Lagendijk JJ, van den Bongard HJ, van Asselen B (2013) MR-guided breast radiotherapy: feasibility and magnetic-field impact on skin dose. Phys Med Biol 58:5917–5930CrossRefPubMed van Heijst TC, den Hartogh MD, Lagendijk JJ, van den Bongard HJ, van Asselen B (2013) MR-guided breast radiotherapy: feasibility and magnetic-field impact on skin dose. Phys Med Biol 58:5917–5930CrossRefPubMed
13.
go back to reference Hackett SL, van Asselen B, Wolthaus JWH et al (2018) Spiraling contaminant electrons increase doses to surfaces outside the photon beam of an MRI-linac with a perpendicular magnetic field. Phys Med Biol 63:95001CrossRefPubMed Hackett SL, van Asselen B, Wolthaus JWH et al (2018) Spiraling contaminant electrons increase doses to surfaces outside the photon beam of an MRI-linac with a perpendicular magnetic field. Phys Med Biol 63:95001CrossRefPubMed
14.
go back to reference Menten MJ, Fast MF, Nill S, Kamerling CP, McDonald F, Oelfke U (2016) Lung stereotactic body radiotherapy with an MR-linac – quantifying the impact of the magnetic field and real-time tumor tracking. Radiother Oncol 119:461–466CrossRefPubMedPubMedCentral Menten MJ, Fast MF, Nill S, Kamerling CP, McDonald F, Oelfke U (2016) Lung stereotactic body radiotherapy with an MR-linac – quantifying the impact of the magnetic field and real-time tumor tracking. Radiother Oncol 119:461–466CrossRefPubMedPubMedCentral
15.
go back to reference Yin L, Wu H, Gong J et al (2012) Volumetric-modulated arc therapy vs. c‑IMRT in esophageal cancer: a treatment planning comparison. World J Gastroenterol 18:5266–5275CrossRefPubMedPubMedCentral Yin L, Wu H, Gong J et al (2012) Volumetric-modulated arc therapy vs. c‑IMRT in esophageal cancer: a treatment planning comparison. World J Gastroenterol 18:5266–5275CrossRefPubMedPubMedCentral
16.
go back to reference Zhang WZ, Zhai TT, Lu JY et al (2015) Volumetric modulated arc therapy vs. c‑IMRT for the treatment of upper thoracic esophageal cancer. PLoS ONE 10:e121385CrossRefPubMedPubMedCentral Zhang WZ, Zhai TT, Lu JY et al (2015) Volumetric modulated arc therapy vs. c‑IMRT for the treatment of upper thoracic esophageal cancer. PLoS ONE 10:e121385CrossRefPubMedPubMedCentral
17.
go back to reference Chuter RW, Whitehurst P, Choudhury A, van Herk M, McWilliam A (2017) Technical note: investigating the impact of field size on patient selection for the 1.5T MR-linac. Med Phys 44:5667–5671CrossRefPubMed Chuter RW, Whitehurst P, Choudhury A, van Herk M, McWilliam A (2017) Technical note: investigating the impact of field size on patient selection for the 1.5T MR-linac. Med Phys 44:5667–5671CrossRefPubMed
18.
go back to reference Bainbridge HE, Menten MJ, Fast MF, Nill S, Oelfke U, McDonald F (2017) Treating locally advanced lung cancer with a 1.5T MR-linac – effects of the magnetic field and irradiation geometry on conventionally fractionated and isotoxic dose-escalated radiotherapy. Radiother Oncol 125(2):280–285CrossRefPubMedPubMedCentral Bainbridge HE, Menten MJ, Fast MF, Nill S, Oelfke U, McDonald F (2017) Treating locally advanced lung cancer with a 1.5T MR-linac – effects of the magnetic field and irradiation geometry on conventionally fractionated and isotoxic dose-escalated radiotherapy. Radiother Oncol 125(2):280–285CrossRefPubMedPubMedCentral
19.
go back to reference Welsh J, Settle SH, Amini A et al (2012) Failure patterns in patients with esophageal cancer treated with definitive chemoradiation. Cancer 118:2632–2640CrossRefPubMed Welsh J, Settle SH, Amini A et al (2012) Failure patterns in patients with esophageal cancer treated with definitive chemoradiation. Cancer 118:2632–2640CrossRefPubMed
20.
go back to reference Geh JI, Bond SJ, Bentzen SM, Glynne-Jones R (2006) Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response. Radiother Oncol 78:236–244CrossRefPubMed Geh JI, Bond SJ, Bentzen SM, Glynne-Jones R (2006) Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response. Radiother Oncol 78:236–244CrossRefPubMed
21.
go back to reference Minsky BD, Pajak TF, Ginsberg RJ et al (2002) INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 20:1167–1174CrossRefPubMed Minsky BD, Pajak TF, Ginsberg RJ et al (2002) INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 20:1167–1174CrossRefPubMed
22.
go back to reference Fusco R, Petrillo M, Granata V et al (2017) Magnetic resonance imaging evaluation in neoadjuvant therapy of locally advanced rectal cancer: a systematic review. Radiol Oncol 51:252–262CrossRefPubMedPubMedCentral Fusco R, Petrillo M, Granata V et al (2017) Magnetic resonance imaging evaluation in neoadjuvant therapy of locally advanced rectal cancer: a systematic review. Radiol Oncol 51:252–262CrossRefPubMedPubMedCentral
23.
go back to reference Jones M, Hruby G, Stanwell P et al (2015) Multiparametric MRI as an outcome predictor for anal canal cancer managed with chemoradiotherapy. BMC Cancer 15:281CrossRefPubMedPubMedCentral Jones M, Hruby G, Stanwell P et al (2015) Multiparametric MRI as an outcome predictor for anal canal cancer managed with chemoradiotherapy. BMC Cancer 15:281CrossRefPubMedPubMedCentral
24.
go back to reference Thorwarth D, Notohamiprodjo M, Zips D, Muller AC (2017) Personalized precision radiotherapy by integration of multi-parametric functional and biological imaging in prostate cancer: a feasibility study. Z Med Phys 27:21–30CrossRefPubMed Thorwarth D, Notohamiprodjo M, Zips D, Muller AC (2017) Personalized precision radiotherapy by integration of multi-parametric functional and biological imaging in prostate cancer: a feasibility study. Z Med Phys 27:21–30CrossRefPubMed
25.
Metadata
Title
Comparison of treatment plans for a high-field MRI-linac and a conventional linac for esophageal cancer
Authors
Marcel Nachbar
David Mönnich
Paul Kalwa
Daniel Zips
Daniela Thorwarth
Dr. Cihan Gani
Publication date
01-04-2019
Publisher
Springer Berlin Heidelberg
Published in
Strahlentherapie und Onkologie / Issue 4/2019
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-018-1386-z

Other articles of this Issue 4/2019

Strahlentherapie und Onkologie 4/2019 Go to the issue